Discussion of the history of animal drug compounding law, where it sits today, and where it will be in the future.
Learning Objectives:
Upon completion, participants will be able to distinguish between FDA and State BOP requirements concerning animal compounding.
Upon completion, participants will be able to better understand GFI 256.
Upon completion, participants will be able to better understand the ability to compound from bulk in both a 503A and a 503B.
Upon completion, participants will be able to understand the legal status of compounding FDA-approved human drugs on the shortage list for animal purposes.
